Evaluation of the anti-inflammatory effects of two platelet-rich gel supernatants in an in vitro system of cartilage inflammation
Abstract
Objectives: To study, in normal cartilage explants (CEs) challenged with lipopolysaccharide (LPS), the temporal effects (at 48 and 96 h) of leukocyte- and platelet-rich gel (L-PRG) and pure platelet-rich gel (P-PRG) supernatants on the production and degradation of platelet-associated growth factors (GFs) (platelet-derived GF isoform BB [PDGF-BB] and transforming growth factor beta-1 [TGF-beta(1)]), pro-inflammatory (tumour necrosis factor alpha [TNF-alpha]) and anti-inflammatory cytokines (interleukin 4 [IL-4] and IL-1 receptor antagonist [IL-1ra]). Methods: CEs from six horses were challenged with LPS and cultured for 96 h with L-PRG and P-PRG supernatants at concentrations of 25% and 50%, respectively. The CE culture medium was changed every 48 h and used for determination, by ELISA, of PDGF-BB, TGF-beta(1)], TNF-alpha, IL-4 and IL-1ra. Results: Both the 25% and 50% PRG supernatants produced a different molecular profile in the culture media, unlike that of the CE challenged with LPS only. 50% L-PRG produced the most sustained release of growth factors and anti-inflammatory cytokines, although it produced the highest TNF-alpha release. PDGF-BB was significantly correlated with IL-1ra and TNF-alpha, concentrations, whereas TNF-alpha was correlated with IL-4. Conclusions: 50% L-PRG supernatant produced a more sustained concentration of growth factors and anti-inflammatory cytokines than the other hemoderivatives evaluated. This substance could be evaluated in animal models of arthritis or in patients with arthropathies. (C) 2015 Elsevier Ltd. All rights reserved.
Más información
| Título según WOS: | ID WOS:000364244400050 Not found in local WOS DB |
| Título de la Revista: | CYTOKINE |
| Volumen: | 76 |
| Número: | 2 |
| Editorial: | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD |
| Fecha de publicación: | 2015 |
| Página de inicio: | 505 |
| Página final: | 513 |
| DOI: |
10.1016/j.cyto.2015.07.008 |
| Notas: | ISI |